
Novartis plans $23B expansion of manufacturing in NJ, US
Besides, Novartis, Johnson & Johnson plans to spend $55 billion over four years on domestic manufacturing, research and technology. Merck announced plans to spend $1 billion on a vaccine manufacturing site in North Carolina, plus $8 billion on other …